Dorra Pharma engages in CDMO for small molecules, with our supplier network of over 3'000 manufacturers we are able to build your sustainable and robust supply chain and fine any product, even if difficult through our end-to-end supply management. Dorra is looking to in-license Drug Product for the Chinese market with unmet medical needs, low competition or niche applications. We take care of registration, and have a sound distribution network for hospitals, pharmacies and online pharmacies with our own reps. Through our JV we have developed our proprietary LNP drug delivery development system Lipoeasy with higher performance than competitor kits.